Inventor
Scott D. Bembenek
Inventor
San Diego, CA, US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
C07DHeterocyclic compounds39%
A61KPreparations for medical, dental or toiletry purposes22%
PatentTitleYear
10,934,310Inhibitors of Bruton's tyrosine kinase and method of their use202110,822,348Inhibitors of Bruton's tyrosine kinase and methods of their use202010,800,792Inhibitors of Bruton's tyrosine kinase and method of their use202010,717,745Inhibitors of Bruton's tyrosine kinase and method of their use202010,689,396Inhibitors of Bruton's tyrosine kinase and methods of their use20208,937,078'Quinazolinones as prolyl hydroxylase inhibitors'20158,367,719'Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase'20138,344,008'Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolase'20137,935,725'Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2021Patents assigned to JANSSEN PHARMACEUTICA NV (9)· patent assignee history
2011–2021Based in San Diego, CA, US· patent location history
2013–2015Patents assigned to BEMBENEK SCOTT D (3)· patent assignee history
2013Patents assigned to BACANI GENESIS M (2)· patent assignee history
2013Patents assigned to ECCLES WENDY (2)· patent assignee history
2013Patents assigned to EDWARDS JAMES P (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 9 | 2011–2021 |
| BEMBENEK SCOTT Dself | 3 | 2013–2015 |
| BACANI GENESIS M | 2 | 2013 |
| ECCLES WENDY | 2 | 2013 |
| EDWARDS JAMES P | 2 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 9 | 2011–2021 |